Literature DB >> 33726831

Exploration and validation of related hub gene expression during SARS-CoV-2 infection of human bronchial organoids.

Ke-Ying Fang1,2, Wen-Chao Cao1,2, Tian-Ao Xie1,2, Jie Lv1,2, Jia-Xin Chen1,2, Xun-Jie Cao1,2, Zhong-Wei Li1,2, Shu-Ting Deng1,2, Xu-Guang Guo3,4,5,6.   

Abstract

BACKGROUND: In the novel coronavirus pandemic, the high infection rate and high mortality have seriously affected people's health and social order. To better explore the infection mechanism and treatment, the three-dimensional structure of human bronchus has been employed in a better in-depth study on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
METHODS: We downloaded a separate microarray from the Integrated Gene Expression System (GEO) on a human bronchial organoids sample to identify differentially expressed genes (DEGS) and analyzed it with R software. After processing with R software, Gene Ontology (GO) and Kyoto PBMCs of Genes and Genomes (KEGG) were analyzed, while a protein-protein interaction (PPI) network was constructed to show the interactions and influence relationships between these differential genes. Finally, the selected highly connected genes, which are called hub genes, were verified in CytoHubba plug-in.
RESULTS: In this study, a total of 966 differentially expressed genes, including 490 upregulated genes and 476 downregulated genes were used. Analysis of GO and KEGG revealed that these differentially expressed genes were significantly enriched in pathways related to immune response and cytokines. We construct protein-protein interaction network and identify 10 hub genes, including IL6, MMP9, IL1B, CXCL8, ICAM1, FGF2, EGF, CXCL10, CCL2, CCL5, CXCL1, and FN1. Finally, with the help of GSE150728, we verified that CXCl1, CXCL8, CXCL10, CCL5, EGF differently expressed before and after SARS-CoV-2 infection in clinical patients.
CONCLUSIONS: In this study, we used mRNA expression data from GSE150819 to preliminarily confirm the feasibility of hBO as an in vitro model to further study the pathogenesis and potential treatment of COVID-19. Moreover, based on the mRNA differentiated expression of this model, we found that CXCL8, CXCL10, and EGF are hub genes in the process of SARS-COV-2 infection, and we emphasized their key roles in SARS-CoV-2 infection. And we also suggested that further study of these hub genes may be beneficial to treatment, prognostic prediction of COVID-19.

Entities:  

Keywords:  3D structure model; Bioinformatics analysis; Human bronchial organoids; Immune response; Novel coronavirus infection

Year:  2021        PMID: 33726831      PMCID: PMC7962432          DOI: 10.1186/s40246-021-00316-5

Source DB:  PubMed          Journal:  Hum Genomics        ISSN: 1473-9542            Impact factor:   4.639


  31 in total

1.  Infection of bat and human intestinal organoids by SARS-CoV-2.

Authors:  Jie Zhou; Cun Li; Xiaojuan Liu; Man Chun Chiu; Xiaoyu Zhao; Dong Wang; Yuxuan Wei; Andrew Lee; Anna Jinxia Zhang; Hin Chu; Jian-Piao Cai; Cyril Chik-Yan Yip; Ivy Hau-Yee Chan; Kenneth Kak-Yuen Wong; Owen Tak-Yin Tsang; Kwok-Hung Chan; Jasper Fuk-Woo Chan; Kelvin Kai-Wang To; Honglin Chen; Kwok Yung Yuen
Journal:  Nat Med       Date:  2020-05-13       Impact factor: 53.440

2.  HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).

Authors:  S Nilsson; G Zador; K G Nygren; L Wide
Journal:  Gynecol Obstet Invest       Date:  1981       Impact factor: 2.031

Review 3.  A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV.

Authors:  Ashutosh Singh; Rahul Soloman Singh; Phulen Sarma; Gitika Batra; Rupa Joshi; Hardeep Kaur; Amit Raj Sharma; Ajay Prakash; Bikash Medhi
Journal:  Virol Sin       Date:  2020-06-30       Impact factor: 4.327

4.  Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.

Authors:  Masaki Imai; Kiyoko Iwatsuki-Horimoto; Masato Hatta; Samantha Loeber; Peter J Halfmann; Noriko Nakajima; Tokiko Watanabe; Michiko Ujie; Kenta Takahashi; Mutsumi Ito; Shinya Yamada; Shufang Fan; Shiho Chiba; Makoto Kuroda; Lizheng Guan; Kosuke Takada; Tammy Armbrust; Aaron Balogh; Yuri Furusawa; Moe Okuda; Hiroshi Ueki; Atsuhiro Yasuhara; Yuko Sakai-Tagawa; Tiago J S Lopes; Maki Kiso; Seiya Yamayoshi; Noriko Kinoshita; Norio Ohmagari; Shin-Ichiro Hattori; Makoto Takeda; Hiroaki Mitsuya; Florian Krammer; Tadaki Suzuki; Yoshihiro Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-22       Impact factor: 11.205

5.  Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein.

Authors:  Ahmed Rakib; Saad Ahmed Sami; Nusrat Jahan Mimi; Md Mustafiz Chowdhury; Taslima Akter Eva; Firzan Nainu; Arkajyoti Paul; Asif Shahriar; Abu Montakim Tareq; Nazim Uddin Emon; Sajal Chakraborty; Sagar Shil; Sabrina Jahan Mily; Taibi Ben Hadda; Faisal A Almalki; Talha Bin Emran
Journal:  Comput Biol Med       Date:  2020-08-13       Impact factor: 4.589

6.  Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.

Authors:  Xi Xu; Chengcheng Yu; Jing Qu; Lieguang Zhang; Songfeng Jiang; Deyang Huang; Bihua Chen; Zhiping Zhang; Wanhua Guan; Zhoukun Ling; Rui Jiang; Tianli Hu; Yan Ding; Lin Lin; Qingxin Gan; Liangping Luo; Xiaoping Tang; Jinxin Liu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-02-28       Impact factor: 9.236

7.  Infection and Rapid Transmission of SARS-CoV-2 in Ferrets.

Authors:  Young-Il Kim; Seong-Gyu Kim; Se-Mi Kim; Eun-Ha Kim; Su-Jin Park; Kwang-Min Yu; Jae-Hyung Chang; Eun Ji Kim; Seunghun Lee; Mark Anthony B Casel; Jihye Um; Min-Suk Song; Hye Won Jeong; Van Dam Lai; Yeonjae Kim; Bum Sik Chin; Jun-Sun Park; Ki-Hyun Chung; Suan-Sin Foo; Haryoung Poo; In-Pil Mo; Ok-Jun Lee; Richard J Webby; Jae U Jung; Young Ki Choi
Journal:  Cell Host Microbe       Date:  2020-04-06       Impact factor: 21.023

8.  Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques.

Authors:  Chao Shan; Yan-Feng Yao; Xing-Lou Yang; Yi-Wu Zhou; Ge Gao; Yun Peng; Lian Yang; Xue Hu; Jin Xiong; Ren-Di Jiang; Hua-Jun Zhang; Xiao-Xiao Gao; Cheng Peng; Juan Min; Ying Chen; Hao-Rui Si; Jia Wu; Peng Zhou; Yan-Yi Wang; Hong-Ping Wei; Wei Pang; Zheng-Fei Hu; Long-Bao Lv; Yong-Tang Zheng; Zheng-Li Shi; Zhi-Ming Yuan
Journal:  Cell Res       Date:  2020-07-07       Impact factor: 25.617

9.  Differentiated human airway organoids to assess infectivity of emerging influenza virus.

Authors:  Jie Zhou; Cun Li; Norman Sachs; Man Chun Chiu; Bosco Ho-Yin Wong; Hin Chu; Vincent Kwok-Man Poon; Dong Wang; Xiaoyu Zhao; Lei Wen; Wenjun Song; Shuofeng Yuan; Kenneth Kak-Yuen Wong; Jasper Fuk-Woo Chan; Kelvin Kai-Wang To; Honglin Chen; Hans Clevers; Kwok-Yung Yuen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-11       Impact factor: 11.205

Review 10.  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review.

Authors:  Wei Feng; Wei Zong; Feng Wang; Shaoqing Ju
Journal:  Mol Cancer       Date:  2020-06-02       Impact factor: 41.444

View more
  4 in total

Review 1.  Human organoid models to study SARS-CoV-2 infection.

Authors:  Yuling Han; Liuliu Yang; Lauretta A Lacko; Shuibing Chen
Journal:  Nat Methods       Date:  2022-04-08       Impact factor: 28.547

2.  Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs Repurposing.

Authors:  Md Parvez Mosharaf; Md Kaderi Kibria; Md Bayazid Hossen; Md Ariful Islam; Md Selim Reza; Rashidul Alam Mahumud; Khorshed Alam; Jeff Gow; Md Nurul Haque Mollah
Journal:  Vaccines (Basel)       Date:  2022-08-03

3.  LncRNAs harbouring regulatory motifs within repeat elements modulate immune response towards COVID-19 disease severity and clinical outcomes.

Authors:  Partha Chattopadhyay; Pallavi Mishra; Kriti Khare; Aanchal Yadav; Priyanka Mehta; Sheeba Saifi; Aparna Swaminathan; Priti Devi; Shaista Parveen; Akansha Tyagi; Vinita Jha; Bansidhar Tarai; Sujeet Jha; Sandeep Budhiraja; Jitendra Narayan; Rajesh Pandey
Journal:  Clin Transl Med       Date:  2022-07

4.  The Severity of COVID-19 Affects the Plasma Soluble Levels of the Immune Checkpoint HLA-G Molecule.

Authors:  Jéssica F C Cordeiro; Talita M Fernandes; Diana M Toro; Pedro V da Silva-Neto; Vinícius E Pimentel; Malena M Pérez; Jonatan C S de Carvalho; Thais F C Fraga-Silva; Camilla N S Oliveira; Jamille G M Argolo; Augusto M Degiovani; Fátima M Ostini; Enrico F Puginna; João S da Silva; Isabel K F M Santos; Vânia L D Bonato; Cristina R B Cardoso; Marcelo Dias-Baruffi; Lúcia H Faccioli; Eduardo A Donadi; Carlos A Sorgi; Ana P M Fernandes
Journal:  Int J Mol Sci       Date:  2022-08-27       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.